US EditionPublished • loading... • Updated
BeOne Medicines Showcases Leadership in B-cell Malignancies at ASH 2025
Summary by Mid Florida Newspapers
4 Articles
4 Articles
BeOne Medicines Showcases Leadership in B-cell Malignancies at ASH 2025
SAN CARLOS, Calif. -- BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, advances its vision to become the world’s leading oncology company with extensive new data from its differentiated hematology portfolio at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition in Orlando, Florida, December 6-9. Nearly 50 abstracts have been accepted, including six oral presentations, featuring the …
·Canada
Read Full Article
Coverage Details
Total News Sources4
Leaning Left0Leaning Right1Center2Last UpdatedBias Distribution67% Center
Bias Distribution
- 67% of the sources are Center
67% Center
C 67%
R 33%
Factuality
To view factuality data please Upgrade to Premium
